Nonhormonal treatment regimens improve survival in patients with metastatic breast ca

[News]

Nonhormonal treatment regimens, including anthracycline-based regimens and taxanes, have improved overall survival in women with advanced (metastatic or recurrent inoperable) breast cancer over the last 35 years, according to a systematic review published December 9 in the Journal of the National Cancer Institute.

More... (http://www.news-medical.net/?id=44066)